论文部分内容阅读
北京万泰生物药业股份有限公司隶属于养生堂有限公司,专注于疫苗研发及生产的高新技术企业,已发展成为亚太最大的艾滋诊断试剂生产基地,其产品在省级血液中心市场占有率达到90%,是中国最大的免疫诊断试剂以及国家生物高新技术产业化示范工程基地,承担国家863计划、十五攻关、科技部十一五、十二五支撑计划及教育部、省(市)重点攻关等十余项科研项目。
Beijing Wantai Bio-Pharmaceutical Co., Ltd., a subsidiary of Yangshengtang Co., Ltd., is a high-tech enterprise focusing on vaccine R & D and production and has grown into the largest production base of AIDS diagnostic reagent in the Asia-Pacific region. Its products occupy a market share of provincial blood centers 90%, is China’s largest immunodiagnostic reagents and national biological high-tech industrialization demonstration project base, to undertake the national 863 plan, 15 research, Ministry of Science and Eleventh Five-Year Plan, Ministry of Education and the Ministry of Education, provincial (city) focus Research and more than 10 research projects.